Basic Information
| RNALocate ID: | RLID-D:11000103 |
| RNA Symbol: | hsa-miR-194-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-194-5p |
| RNA ID: | miRBase:MIMAT0000460 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Colon tissue |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001856 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:11001983 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
| RLID:11001984 | Exosome | Brain tissue | 23382797 |
| RLID:11001985 | Exosome | Plasma | 23663360 |
| RLID:11001986 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000388 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-194-5p | Medulloblastoma | MNDR-E-MI-23387 |
| MNDR | hsa-miR-194-5p | Small intestinal neuroendocrine tumor | MNDR-E-MI-23388 |
| MNDR | hsa-miR-194-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-23389 |
| MNDR | hsa-miR-194-5p | Lymphoma | MNDR-E-MI-23390 |
| MNDR | hsa-miR-194-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-23391 |
| MNDR | hsa-miR-194-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-23392 |
| MNDR | hsa-miR-194-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-23393 |
| MNDR | hsa-miR-194-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-23394 |
| MNDR | hsa-miR-194-5p | Her2-receptor positive breast cancer | MNDR-E-MI-23395 |
| MNDR | hsa-miR-194-5p | Breast cancer luminal | MNDR-E-MI-23396 |
| MNDR | hsa-miR-194-5p | Autoimmune lymphoproliferative syndrome type 4 | MNDR-E-MI-23397 |
| MNDR | hsa-miR-194-5p | Dermatomyositis | MNDR-E-MI-23398 |
| MNDR | hsa-miR-194-5p | Prostate cancer | MNDR-E-MI-23399 |
| MNDR | hsa-miR-194-5p | Gastric cancer | MNDR-E-MI-23400 |
| MNDR | hsa-miR-194-5p | Alzheimer disease | MNDR-E-MI-23401 |
| MNDR | hsa-miR-194-5p | Intracranial aneurysm | MNDR-E-MI-23402 |
| MNDR | hsa-miR-194-5p | Urinary bladder cancer | MNDR-E-MI-23403 |
| MNDR | hsa-miR-194-5p | Dysautonomia familial | MNDR-E-MI-23404 |
| MNDR | hsa-miR-194-5p | Myotonic dystrophy | MNDR-E-MI-23405 |
| MNDR | hsa-miR-194-5p | Seizures | MNDR-E-MI-23406 |
| MNDR | hsa-miR-194-5p | Head and neck cancer | MNDR-E-MI-23407 |
| MNDR | hsa-miR-194-5p | Leukemia | MNDR-E-MI-23408 |
| MNDR | hsa-miR-194-5p | Friedreich ataxia | MNDR-E-MI-23409 |
| MNDR | hsa-miR-194-5p | Huntington disease | MNDR-E-MI-23410 |
| MNDR | hsa-miR-194-5p | Chorea | MNDR-E-MI-23411 |
| MNDR | hsa-miR-194-5p | Cardiovascular disease | MNDR-E-MI-23412 |
| MNDR | hsa-miR-194-5p | Lung cancer | MNDR-E-MI-23413 |
| MNDR | hsa-miR-194-5p | Endometrial cancer | MNDR-E-MI-23414 |
| MNDR | hsa-miR-194-5p | Parkinson disease | MNDR-E-MI-23415 |
| MNDR | hsa-miR-194-5p | Basal-like breast cancer | MNDR-E-MI-23416 |
| MNDR | hsa-miR-194-5p | Pituitary neoplasms | MNDR-E-MI-23417 |
| MNDR | hsa-miR-194-5p | Pancreatic cancer | MNDR-E-MI-23418 |
| MNDR | hsa-miR-194-5p | Melanoma | MNDR-E-MI-23419 |
| MNDR | hsa-miR-194-5p | Rectum adenocarcinoma | MNDR-E-MI-23420 |
| MNDR | hsa-miR-194-5p | Nephroblastoma | MNDR-E-MI-23421 |
| MNDR | hsa-miR-194-5p | Colon cancer | MNDR-E-MI-23422 |
| MNDR | hsa-miR-194-5p | Ischemic attack transient | MNDR-E-MI-23423 |
| MNDR | hsa-miR-194-5p | Colon adenocarcinoma | MNDR-E-MI-23424 |
| MNDR | hsa-miR-194-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-23425 |
| MNDR | hsa-miR-194-5p | Ovarian cancer | MNDR-E-MI-23426 |
| MNDR | hsa-miR-194-5p | Acromegaly | MNDR-E-MI-23427 |
| MNDR | hsa-miR-194-5p | Prostate adenocarcinoma | MNDR-E-MI-23428 |
| MNDR | hsa-miR-194-5p | Kidney cancer | MNDR-E-MI-23429 |
| MNDR | hsa-miR-194-5p | Endometrial carcinoma | MNDR-E-MI-23430 |
| MNDR | hsa-miR-194-5p | Endometriosis | MNDR-E-MI-23431 |
| MNDR | hsa-miR-194-5p | Carcinoma ductal breast | MNDR-E-MI-23432 |
| MNDR | hsa-miR-194-5p | Glioblastoma | MNDR-E-MI-23433 |
| MNDR | hsa-miR-194-5p | Astrocytoma | MNDR-E-MI-23434 |
| MNDR | hsa-miR-194-5p | Glioma | MNDR-E-MI-23435 |
| MNDR | hsa-miR-194-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-23436 |
| MNDR | hsa-miR-194-5p | Osteosarcoma | MNDR-E-MI-23437 |
| MNDR | hsa-miR-194-5p | Liposarcoma | MNDR-E-MI-23438 |
| MNDR | hsa-miR-194-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-23439 |
| MNDR | hsa-miR-194-5p | Liver cancer | MNDR-E-MI-23440 |
| MNDR | hsa-miR-194-5p | Uterus cancer | MNDR-E-MI-23441 |
| MNDR | hsa-miR-194-5p | Cervical adenocarcinoma | MNDR-E-MI-23442 |
| MNDR | hsa-miR-194-5p | Gastric adenocarcinoma | MNDR-E-MI-23443 |
| MNDR | hsa-miR-194-5p | Pituitary adenoma | MNDR-E-MI-23444 |
| MNDR | hsa-miR-194-5p | Lung squamous cell carcinoma | MNDR-E-MI-23445 |
| MNDR | hsa-miR-194-5p | Lung adenocarcinoma | MNDR-E-MI-23446 |
| MNDR | hsa-miR-194-5p | Bladder urothelial carcinoma | MNDR-E-MI-23447 |
| MNDR | hsa-miR-194-5p | Pancreatic adenocarcinoma | MNDR-E-MI-23448 |
| MNDR | hsa-miR-194-5p | Carcinoma renal cell | MNDR-E-MI-23449 |
| MNDR | hsa-miR-194-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-23450 |
| MNDR | hsa-miR-194-5p | Clear cell renal cell carcinoma | MNDR-E-MI-23451 |
| MNDR | hsa-miR-194-5p | Chromophobe renal cell carcinoma | MNDR-E-MI-23452 |
| MNDR | hsa-miR-194-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-23453 |
| MNDR | hsa-miR-194-5p | Cholangiocarcinoma | MNDR-E-MI-23454 |
| MNDR | hsa-miR-194-5p | Esophageal cancer | MNDR-E-MI-23455 |
| MNDR | hsa-miR-194-5p | Liver cirrhosis | MNDR-E-MI-23456 |
| MNDR | hsa-miR-194-5p | Oncocytoma | MNDR-E-MI-23457 |
| MNDR | hsa-miR-194-5p | T acute lymphoblastic leukemia | MNDR-E-MI-23458 |
| MNDR | hsa-miR-194-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-23459 |
| MNDR | hsa-miR-194-5p | Breast invasive carcinoma | MNDR-E-MI-23460 |
| MNDR | hsa-miR-194-5p | Hepatocellular carcinoma | MNDR-E-MI-23461 |
| MNDR | hsa-miR-194-5p | B-cell lymphoma | MNDR-E-MI-23462 |
| MNDR | hsa-miR-194-5p | Rheumatoid arthritis | MNDR-E-MI-23463 |
| MNDR | hsa-miR-194-5p | T-cell leukemia | MNDR-E-MI-23464 |
| MNDR | hsa-miR-194-5p | Retinoblastoma | MNDR-E-MI-23465 |
| MNDR | hsa-miR-194-5p | Neuroblastoma | MNDR-E-MI-23466 |
| MNDR | hsa-miR-194-5p | Barrett's adenocarcinoma | MNDR-E-MI-23467 |
| MNDR | hsa-miR-194-5p | Hodgkin lymphoma | MNDR-E-MI-23468 |
| MNDR | hsa-miR-194-5p | Burkitt lymphoma | MNDR-E-MI-23469 |
| MNDR | hsa-miR-194-5p | Neuromyelitis optica | MNDR-E-MI-23470 |
| MNDR | hsa-miR-194-5p | Acute myelocytic leukemia | MNDR-E-MI-23471 |
| MNDR | hsa-miR-194-5p | Colorectal cancer | MNDR-E-MI-23472 |
| MNDR | hsa-miR-194-5p | Nasopharynx carcinoma | MNDR-E-MI-23473 |
| MNDR | hsa-miR-194-5p | Multiple myeloma | MNDR-E-MI-23474 |
| MNDR | hsa-miR-194-5p | Diabetic nephropathies | MNDR-E-MI-23475 |
| MNDR | hsa-miR-194-5p | Ependymoma | MNDR-E-MI-23476 |
| MNDR | hsa-miR-194-5p | Graft vs host disease | MNDR-E-MI-23477 |
| MNDR | hsa-miR-194-5p | Cardiac hypertrophy | MNDR-E-MI-23478 |
| MNDR | hsa-miR-194-5p | Nasopharyngeal cancer | MNDR-E-MI-23479 |
| MNDR | hsa-miR-194-5p | Pseudorabies | MNDR-E-MI-23480 |
| MNDR | hsa-miR-194-5p | Osteoporosis postmenopausal | MNDR-E-MI-23481 |
| MNDR | hsa-miR-194-5p | Epstein-barr virus infections | MNDR-E-MI-23482 |
| MNDR | hsa-miR-194-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-23483 |
| MNDR | hsa-miR-194-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-23484 |
| MNDR | hsa-miR-194-5p | Gait ataxia | MNDR-E-MI-23485 |
| MNDR | hsa-miR-194-5p | Pancreatitis chronic | MNDR-E-MI-23486 |
| MNDR | hsa-miR-194-5p | Stroke lacunar | MNDR-E-MI-23487 |
| MNDR | hsa-miR-194-5p | Barrett's carcinogenesis | MNDR-E-MI-23488 |
| MNDR | hsa-miR-194-5p | Renal childhood neoplasms | MNDR-E-MI-23489 |
| MNDR | hsa-miR-194-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-23490 |
| MNDR | hsa-miR-194-5p | Tubulovillous adenoma | MNDR-E-MI-23491 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACVR2B | Homo sapiens | RR00039536 |
TOP